Evaluation of anti-cancer and immunomodulatory effects of carnosol in a Balb/c WEHI-164 fibrosarcoma model

Journal of Immunotoxicology

Volumn 12, Issue 3, 2015, Pages 231-238

  Rahnama, Maryam ^a   Mahmoudi, Mahmoud ^b   Zamani Taghizadeh Rabe, Shahrzad ^a   Balali Mood, Mahdi ^c   Karimi, Gholamreza ^c   Tabasi, Nafiseh ^a   Riahi Zanjani, Bamdad ^c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti tumor; Balb c; Carnosol; Regulatory T cell

Indexed keywords

ANTINEOPLASTIC AGENT; CARNOSOL; CD4 ANTIGEN; CYCLOPHOSPHAMIDE; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; TRANSCRIPTION FACTOR FOXP3; ABIETANE DERIVATIVE; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FIBROSARCOMA; IMMUNOMODULATION; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION; TREATMENT DURATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR VOLUME; ANIMAL; BAGG ALBINO MOUSE; CELL GROWTH; DRUG EFFECTS; HUMAN; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE ACTIVATION; METABOLISM; NEOPLASMS, EXPERIMENTAL; ROSMARINUS; TUMOR CELL LINE;

MUS;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CYTOKINES; DITERPENES, ABIETANE; FIBROSARCOMA; HUMANS; IMMUNOMODULATION; INJECTIONS, INTRAPERITONEAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; ROSMARINUS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TUMOR BURDEN;

EID: 84928598412     PISSN: 1547691X     EISSN: 15476901     Source Type: Journal    
DOI: 10.3109/1547691X.2014.934975     Document Type: Article

References (42)

1. Altinier, G., Sosa, S., Aquino, R. P., et al. 2007. Characterization of topical anti-inflammatory compounds in Rosmarinus officinalis L. J. Agric. Food Chem. 55:1718-1723.
2. Aruoma, O., Hlliwell, B., Aeschbach, R., and Loligers, J. 1992. Antioxidant and pro-oxidant properties of active rosemary constituents: Carnosol and carnosic acid. Xenobiotica 22:257-268.
3. Beninca, J. P., Dalmarco, J. B., Pizzolatti, M. G., and Frode, T. S. 2011. Analysis of the anti-inflammatory properties of Rosmarinus officinalis L. in mice. Food Chem. 124:468-475.
4. Beyer, M., and Schultze, J. L. 2006. Regulatory T-cells in cancer. Blood 108:804-811.
5. Bhardwaj, N. 2007. Harnessing the immune system to treat cancer. J. Clin. Invest. 117:1130-1136.
6. Cao, X., Cai, S. F., Fehniger, T. A., et al. 2007. Granzyme B and perforin are important for regulatory T-cell-mediated suppression of tumor clearance. Immunity 27:635-646.
7. Celiktas, O. Y., Kocabas, E., Bedir, E., et al. 2007. Anti-microbial activities of methanol extracts and essential oils of Rosmarinus officinalis, depending on location and seasonal variations. Food Chem. 100:553-559.
8. Curiel, T. 2007. Treg cells and rethinking cancer immunotherapy. Clin. Invest. 117:1167-1174.
9. de Albuquerque, U. P., Demedeiros, P. M., de Almeida, A. L., et al. 2007. Medicinal plants of the caatinga (semi-arid) vegetation of NE Brazil: A quantitative approach. J. Ethnopharmacol. 114:325-354.
10. Dorrie, J., Sapala, K., and Zunino, S. J. 2001. Carnosol-induced apoptosis and down-regulation of Bcl-2 in B-lineage leukemia cells. Cancer Lett. 170:33-39.
11. Facciabene, A., Motz, G. T., and Coukos, G. 2012. T-Regulatory cells: Key players in tumor immune escape and angiogenesis. Cancer Res. 72:2162-2171.
12. Farsam, V., Hassan, Z. M., Zavaran-Hosseini, A., et al. 2011. Anti-tumor and immunomodulatory properties of artemether and its ability to reduce CD4+CD25+ FoxP3+ Treg cells in vivo. Int. Immunopharmacol. 11:1802-1808.
13. Finn, O. J. 2008. Molecular origins of cancer: Cancer immunology. Medicine 358:2704-2715.
14. Gajhede, M., Anthoni, U., Nielsen, H. P., et al. 1990. Carnosol. Crystal structure, absolute configuration, and spectroscopic properties of a diterpene. J. Crystallogr. Spectr. Res. 20:165-171.
15. Gerloni, M., and Zanetti, M. 2005. CD4 T-cells in tumor immunity. Springer Sem. Immunopathol. 2005:37-48.
16. Huang, M. T., Ho, C. T., Wang, Z. Y., et al. 1994. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res. 54:701-708.
17. Huang, S. C., Ho, C. T., Lin-Shiau, S. Y., and Lin, J. K. 2005. Carnosol inhibits the invasion of B16/F10 mouse melanoma cells by suppressing metalloproteinase-9 through down-regulating NF-kB and c-Jun. Biochem. Pharmacol. 69:221-232.
18. Johnson, J. J. 2011. Carnosol: A promising anti-cancer and antiinflammatory agent. Cancer Lett. 305:1-7.
19. Johnson, J. J., Syed, D. N., Suh, Y., et al. 2010. Disruption of androgen and estrogen receptor activity in prostate cancer by a novel die-tary diterpene carnosol: Implications for chemoprevention. Cancer Prev. Res. 3:1112-1123.
20. Lai, C. S., Lee, J. H., Ho, C. T., et al. 2009. Rosmanol potently inhibits LPS-induced iNOS and COX-2 expression through down-regulating MAPK, NF-kB, STAT3, and C/EBP signaling pathways. J. Agric. Food Chem. 57:10990-10998.
21. Langroudi, L., Hassan, Z. M., Ebtekar, M., et al. 2010. A comparison of low-dose cyclophosphamide treatment with artemisinin treatment in reducing the number of regulatory T-cells in a murine breast cancer model. Int. Immunopharmacol. 10:1055-1061.
22. Lo, A. H., Liang, Y. C., Lin-Shiau, S. Y., et al. 2002. Carnosol, an antioxidant in rosemary, suppresses inducible nitric oxide synthase through down-regulating NF-kB in mouse macrophages. Carcinogenesis 23: 983-991.
23. Lopez-Jimenez, A., Garcia-Caballero, M., Medina, M. A., and Quesada, A. R. 2013. Anti-angiogenic properties of carnosol and carnosic acid, two major dietary compounds from rosemary. Eur. J. Nutr. 52:85-95.
24. Loser, K., Apelt, J., Voskort, M., et al. 2007. IL-10 controls UV-induced carcinogenesis in mice. J. Immunol. 179:365-371.
25. Moran, A. E., Carothers, A. M., Weyant, M. J., et al. 2005. Carnosol inhibits b-catenin tyrosine phosphorylation and prevents adenoma formation in the C57BL/6J/Min/+(Min/+) mouse. Cancer Res. 65: 1097-1104.
26. Moss, M., Cook, J., Wesnes, K., and Ducket, P. 2003. Aromas of rosemary and lavender essential oils differentially affect cognition and mood in healthy adults. Int. J. Neurosci. 113:15-38.
27. Munne-Bosch, S., Schwarz, K., and Alegre, L. 1999. Response of abietane diterpenes to stress in Rosmarinus officinalis L.: New insights into the function of diterpenes in plants. Free Radical Res. 31: S107-S112.
28. Niedbala, W., Cai, B., Liu, H., et al. 2007. Nitric oxide induces CD4+CD25+Foxp3-regulatory T-cells from CD4+CD25-T-cells via p53, IL-2, and OX40. Proc. Natl. Acad. Sci. USA 104:15478-15483.
29. Nissen, L. R., Mansson, L., Bertelsen, G., et al. 2000. Protection of dehydrated chicken meat by natural anti-oxidants as evaluated by electron spin resonance spectrometry. J. Agric. Food Chem. 48: 5548-5556.
30. Noori, S., Taghikhani, M., Hassan, Z. M., et al. 2010. Tehranolide molecule modulates the immune response, reduce regulatory T-cells, and inhibits tumor growth in vivo. Mol. Immunol. 47:1579-1584.
31. Poeckel, D., Greiner, C., Verhoff, M., et al. 2008. Carnosic acid and carnosol potently inhibit human 5-lipoxygenase and suppress proinflammatory responses of stimulated human polymorphonuclear leukocytes. Biochem. Pharmacol. 76:91-97.
32. Riahi, B., Rafatpanah, H., Mahmoudi, M., et al. 2010. Immunotoxicity of paraquat after subacute exposure to mice. Food Chem. Toxicol. 48: 1627-1631.
33. Sancho, E., Batlle, E., and Clevers, H. 2004. Signaling pathways in intestinal development and cancer. Ann. Rev. Cell Dev. Biol. 20: 695-723.
34. Schmidt, H. H., Ge, Y., Hartmann, F., et al. 2013. HLA Class II tetramers reveal tissue-specific regulatory T cells that suppress T-cell responses in breast carcinoma patients. OncoImmunogy 2:e24962.
35. Sotelo-Felix, J., Martinez-Fong, D., Muriel, P., et al. 2002. Evaluation of the effectiveness of Rosmarinus officinalis (Lamiaceae) in the alleviation of carbon tetrachloride-induced acute hepatotoxicity in the rat. J. Ethnopharmacol. 81:145-154.
36. Steer, H., Lake, R., Nowak, A., and Robinson, B. 2010. Harnessing the immune response to treat cancer. Oncogene 29: 6301-6313.
37. Takaki, I., Bersani-Amado, L., Vendruscolo, A., et al. 2008. Antiinflammatory and anti-nociceptive effects of Rosmarinus officinalis L. essential oil in experimental animal models. J. Med. Food 11:741-746.
38. Vignali, D., Collison, L., and Workman, C. 2008. How regulatory T-cells work. Nat. Rev. Immunol. 8:523-532.
39. Witz, I., and Levy-Nissenbaum, O. 2006. The tumor microenvironment in the post-PAGET era. Cancer Lett. 242:1-10.
40. Ya-Mei Yu, M., Lin, C. H., and Hong-Der Tsai, M. 2009. Carnosic acid reduces cytokine-induced adhesion molecules expression and monocyte adhesion to endothelial cells. Eur. J. Nutr. 48:101-106.
41. Zitvogel, L., Apetoh, L., Ghiringhelli, F., et al. 2008. The anti-cancer immune response: Indispensable for therapeutic success? Clin. Invest. 118:1991-2001.
42. Zunino, S. J., and Storms, D. H. 2008. Carnosol delays chemotherapyinduced DNA fragmentation and morphological changes associated with apoptosis in leukemic cells. Nutr. Cancer 61:94-102.